Monthly Archives

April 2017

Virginia Department of Commerce

By | Organizations | No Comments

The Secretary of Commerce and Trade oversees the economic, community, and workforce development of the Commonwealth. Each of the 13 Commerce and Trade Agencies actively contributes to Virginia’s economic health and high quality of life.

The Commonwealth of Virginia was founded as a business venture more than 400 years ago, and is blessed with many assets, including, but not limited to:

  • Low corporate income tax
  • Centrally located – within a 10-hour drive of 60% of the U.S. population
  • Only port on the East Coast deep enough to receive post-Panamax ships
  • Six major interstate highways
  • Fourteen railroads
  • Fourteen airports serving Virginia
  • Higher education system is 11th largest in the nation
  • More than 80,000 graduates in 2013 with associate, bachelor, master, and doctoral degrees
  • Over 500,000 students in 2013 enrolled in over 90 in-state institutions of higher education
  • 23 community colleges: a community college within 30 miles of every resident in Virginia
  • Over 20,000 doctoral scientists and engineers
  • Virginia has the highest concentration (1 in 10) of private sector high-tech workers in America for seven years in a row
  • 15,000 highly-trained veterans exiting the U.S. military each year in Virginia
  • Third lowest unemployment rate east of the Mississippi and lowest unemployment rate in the Southeast

The primary job of the Secretariat of Commerce and Trade is to make sure we utilize these assets to help Virginia sustain its position as the preeminent place to live, work and conduct business.

UK Biobank attracts backing from GSK and Regeneron

By | News | No Comments

GlaxoSmithKline and Regeneron have given their backing to a new project that will use patient data held by the UK Biobank.

The firms will get free access to the samples in return for covering the cost of sequencing it and, after a period of exclusivity, they will then allow the data to be plugged back into the resource for wider use.

The Biobank said the initiative would be the biggest ever genetics study and could usher in a “new era of drug development”.

Join our Mailing List